

The Medibank Private Ltd (ASX: MPL) share price is trading in the red despite the company revealing its highest final dividend since 2019.
Those invested in the company will receive 7.3 cents per share they hold, representing a portion of the $393.9 million full-year after-tax profit posted earlier today.
When combined with the interim dividend of 6.1 cents per share paid in March, this makes Medibank’s FY22 annual dividend also the highest since FY19.
The Medibank share price is trading at $3.50 right now, 0.57% lower than its previous close.
For comparison, the S&P/ASX 200 Index (ASX: XJO) is currently down 0.3%.
Letâs take a closer look at the latest news from the insurance-focused healthcare company.
Medibank share price slumps on full-year earnings
The Medibank share price is struggling on Thursday following the release of the companyâs financial year 2022 earnings.
As my Foolish colleague Aaron reported earlier today, Medibank’s full-year net profit represented a 10.9% year-over-year (yoy) fall.
Meanwhile, its revenue from external customers lifted 3% yoy to more than $7 billion. Its segment operating profit rose 11.9% to $638 million.
It also expects its underlying claims per policy to grow 2.3% in financial year 2023. That figure has been heralded by analysts.
Barrenjoey analyst Andrew Adams was quoted by The Australian saying such an outlook is “likely better than expected and takes some of the pressure off the need for a step-up in premium rate increases at the next pricing review.â
Medibank CEO David Koczkar said: âThe pandemic has triggered a new focus on health and wellbeing, which we expect to continue. A record number of Australians continue to take out private health insurance, especially younger customers.â
Todayâs dip included, the Medibank share price is 2% higher than it was at the start of 2022. Though, it has fallen 1% since this time last year.
For comparison, the ASX 200 has dumped 6% year to date and 5% over the last 12 months.
The post Medibank share price dips despite dividend boost appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of August 4 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Medibank share price on watch amid âstandout customer growthâ
- How much have Medibank shares paid in dividends over the past 5 years?
- Is this why the NIB share price is lagging Medibank on Friday?
- Medibank shares are currently trading on a 4% dividend yield. How does this compare to NIB?
- Is the Medibank share price a smart buy for rising inflation?
Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/RZ4BQwY
Leave a Reply